Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.10.23
关于对成都深瑞畜产品有限公司增资的通告
2010.10.23
关于开展避免资金占用长效机制建设和落真相形的自查报告
2010.10.23
关于规范财务会计基础事情专项运动的自查和整改报告
2010.10.23
高级治理职员薪酬与绩效审核制度(2010年10月)
2010.09.14
第一届董事会第二十一次聚会决议通告
2010.09.14
中国建银投资证券有限责任公司关于公司使用部分逾额召募资金的保荐意见
2010.09.14
关于签署《召募资金三方羁系协议之增补协议》的通告
2010.09.14
关于在四川省成都会投资设立合资公司的通告
2010.09.14
第一届监事会第十次聚会决议通告
2010.09.14
关于在香港设立子公司的通告
第一页
上一页
143
144
145
146
147
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】